Reiter RJ, Ma Q, Sharma R. Melatonin in Mitochondria: Mitigating Clear and Present Dangers. Physiol (Bethesda Md). 2020;35:86–95.
Hardeland R. COVID-19: Urgent Need to Redesign Anti-inflammatory Strategies for CNS Protection. Central nervous system agents in medicinal chemistry. 2022.
Favero G, Moretti E, Bonomini F, Reiter RJ, Rodella LF, Rezzani R. Promising antineoplastic actions of melatonin. Front Pharmacol. 2018;9:1086.
CAS PubMed PubMed Central Article Google Scholar
Monayo SM, Liu X. The prospective application of melatonin in treating epigenetic dysfunctional diseases. Frontiers in Pharmacology. 2022:1593.
Korkmaz A, Reiter RJ. Epigenetic regulation: a new research area for melatonin? J Pineal Res. 2008;44:41–4.
Lerner AB, Case JD, Takahashi Y, Lee TH, Mori W. Isolation of melatonin, the pineal gland factor that lightens melanocyteS1. J Am Chem Soc. 1958;80:2587-.
Tan D-X, Zheng X, Kong J, Manchester LC, Hardeland R, Kim SJ, et al. Fundamental issues related to the origin of melatonin and melatonin isomers during evolution: relation to their biological functions. Int J Mol Sci. 2014;15:15858–90.
CAS PubMed PubMed Central Article Google Scholar
Paredes SD, Korkmaz A, Manchester LC, Tan D-X, Reiter RJ. Phytomelatonin: a review. J Exp Bot. 2009;60:57–69.
CAS PubMed Article Google Scholar
Reiter RJ, Tan D-x, Manchester LC, Simopoulos AP, Maldonado MD, Flores LJ, et al. Melatonin in edible plants (phytomelatonin): identification, concentrations, bioavailability and proposed functions. World Rev Nutr Diet. 2007;97:211–30.
Manchester LC, Coto-Montes A, Boga JA, Andersen LPH, Zhou Z, Galano A, et al. Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res. 2015;59:403–19.
CAS PubMed Article Google Scholar
Suofu Y, Li W, Jean-Alphonse FG, Jia J, Khattar NK, Li J, et al. Dual role of mitochondria in producing melatonin and driving GPCR signaling to block cytochrome c release. Proceedings of the National Academy of Sciences. 2017;114:E7997-E8006.
Zhao D, Yu Y, Shen Y, Liu Q, Zhao Z, Sharma R, et al. Melatonin synthesis and function: evolutionary history in animals and plants. Front Endocrinol. 2019;10:249.
Zisapel N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br J Pharmacol. 2018;175:3190–9.
CAS PubMed PubMed Central Article Google Scholar
Skwarlo-Sonta K, Majewski P, Markowska M, Oblap R, Olszanska B. Bidirectional communication between the pineal gland and the immune system. Can J Physiol Pharmacol. 2003;81:342–9.
CAS PubMed Article Google Scholar
Hardeland R. Aging, melatonin, and the pro-and anti-inflammatory networks. Int J Mol Sci. 2019;20:1223.
CAS PubMed Central Article Google Scholar
Talib WH, Alsayed AR, Abuawad A, Daoud S, Mahmod AI. Melatonin in cancer treatment: Current knowledge and future opportunities. Molecules. 2021;26:2506.
CAS PubMed PubMed Central Article Google Scholar
Mao L, Summers W, Xiang S, Yuan L, Dauchy RT, Reynolds A, et al. Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 ExpressionMelatonin Represses Rsk of Breast Cancer Metastasis. Mol Cancer Res. 2016;14:1159–69.
CAS PubMed PubMed Central Article Google Scholar
Wang SW, Tai HC, Tang CH, Lin LW, Lin TH, Chang AC, et al. Melatonin impedes prostate cancer metastasis by suppressing MMP-13 expression. J Cell Physiol. 2021;236:3979–90.
CAS PubMed Article Google Scholar
Dubocovich ML. Melatonin receptors: role on sleep and circadian rhythm regulation. Sleep Med. 2007;8:34–42.
Becker-André M, Wiesenberg I, Schaeren-Wiemers N, André E, Missbach M, Saurat J-H, et al. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem. 1994;269:28531–4.
Ma H, Kang J, Fan W, He H, Huang F. ROR: Nuclear receptor for melatonin or not? Molecules. 2021;26:2693.
CAS PubMed PubMed Central Article Google Scholar
Boutin JA, Ferry G. Is there sufficient evidence that the melatonin binding site MT3 is quinone reductase 2? J Pharmacol Exp Ther. 2019;368:59–65.
CAS PubMed Article Google Scholar
Hunt AE, Al-Ghoul WM, Gillette MU, Dubocovich ML. Activation of MT2 melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock. Am J Physiology-Cell Physiol. 2001;280:C110-C8.
Jockers R, Maurice P, Boutin J, Delagrange P. Melatonin receptors, heterodimerization, signal transduction and binding sites: what’s new? Br J Pharmacol. 2008;154:1182–95.
CAS PubMed PubMed Central Article Google Scholar
Dubocovich ML, Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine. 2005;27:101–10.
CAS PubMed Article Google Scholar
Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS, Slominski AT. Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol. 2012;351:152–66.
CAS PubMed PubMed Central Article Google Scholar
Capote-Moreno A, Ramos E, Egea J, López-Muñoz F, Gil-Martín E, Romero A. Potential of melatonin as adjuvant therapy of oral cancer in the era of epigenomics. Cancers. 2019;11:1712.
CAS PubMed Central Article Google Scholar
Cavalli G, Heard E. Advances in epigenetics link genetics to the environment and disease. Nature. 2019;571:489–99.
CAS PubMed Article Google Scholar
Moosavi A, Ardekani AM. Role of epigenetics in biology and human diseases. Iran Biomed J. 2016;20:246.
PubMed PubMed Central Google Scholar
Bates SE. Epigenetic therapies for cancer. N Engl J Med. 2020;383:650–63.
CAS PubMed Article Google Scholar
Cheng Y, He C, Wang M, Ma X, Mo F, Yang S, et al. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Signal Transduct Target therapy. 2019;4:1–39.
Surace AEA, Hedrich CM. The role of epigenetics in autoimmune/inflammatory disease. Frontiers in immunology. 2019:1525.
Prasher D, Greenway SC, Singh RB. The impact of epigenetics on cardiovascular disease. Biochem Cell Biol. 2020;98:12–22.
CAS PubMed Article Google Scholar
Ling C, Rönn T. Epigenetics in human obesity and type 2 diabetes. Cell Metabol. 2019;29:1028–44.
Klutstein M, Nejman D, Greenfield R, Cedar H. DNA Methylation in Cancer and Aging. Cancer Res. 2016;76:3446–50.
CAS PubMed Article Google Scholar
Angeloni A, Bogdanovic O. Sequence determinants, function, and evolution of CpG islands. Biochem Soc Trans. 2021;49:1109–19.
CAS PubMed PubMed Central Article Google Scholar
Carlberg C, Molnár F. Human epigenomics. Springer; 2018.
Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16:6–21.
CAS PubMed Article Google Scholar
Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science. 2001;293:1089–93.
CAS PubMed Article Google Scholar
Kim M, Costello J. DNA methylation: an epigenetic mark of cellular memory. Exp Mol Med. 2017;49:e322-e. doi:https://doi.org/10.1038/emm.2017.10.
Noroozi R, Ghafouri-Fard S, Pisarek A, Rudnicka J, Spólnicka M, Branicki W, et al. DNA methylation-based age clocks: from age prediction to age reversion. Ageing Res Rev. 2021;68:101314.
CAS PubMed Article Google Scholar
Skvortsova K, Stirzaker C, Taberlay P. The DNA methylation landscape in cancer. Essays Biochem. 2019;63:797–811.
CAS PubMed PubMed Central Article Google Scholar
Wilson AG. Epigenetic regulation of gene expression in the inflammatory response and relevance to common diseases. J Periodontol. 2008;79:1514–9.
CAS PubMed Article Google Scholar
Magaña-Acosta M, Valadez-Graham V. Chromatin remodelers in the 3D nuclear compartment. Frontiers in Genetics. 2020:1344.
Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet. 2008;9:465–76.
CAS PubMed Article Google Scholar
Ng H-H, Zhang Y, Hendrich B, Johnson CA, Turner BM, Erdjument-Bromage H, et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet. 1999;23:58–
留言 (0)